Product Information
DESCOVY 200-25 MG TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $74.9415 per EA under NDC 61958200202. Its NADAC has been published 337 times since Mar 11, 2020.
FDA first approved this application on Apr 4, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200; 25 mg/1; mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958200202
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
6/29/2026
Active Ingredients
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA208215FDA Approved
4/4/2016
TE Code
AB
On Market Since
4/4/2016
Pharmacological Classes
Price Statistics
The NADAC for DESCOVY 200-25 MG TABLET has been published 337 times since Mar 11, 2020, and over the history we have for it it has risen 25.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $74.9415 per EA |
|---|---|
| All-time high | $74.9415 (Aug 19, 2026) |
| All-time low | $59.6679 (Oct 21, 2020) |
| 52-week high | $74.9415 |
| 52-week low | $71.3223 |
| Median price | $70.0275 |
| Average price | $67.5297 |
| Largest weekly change | +5.9% (Jan 11, 2023) |
| Weeks tracked | 337 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DESCOVY 200-25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DESCOVY 200-25 MG TABLET, manufactured by Gilead Sciences, Inc., is $74.9415 per EA (NDC 61958200202), effective Aug 19, 2026.
How has the price of DESCOVY 200-25 MG TABLET changed over time?
Over the history we have for it, the NADAC for DESCOVY 200-25 MG TABLET has risen 25.6%. It has been tracked across 337 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for DESCOVY 200-25 MG TABLET?
Since Mar 11, 2020, the NADAC for DESCOVY 200-25 MG TABLET has ranged from a low of $59.6679 (Oct 21, 2020) to a high of $74.9415 (Aug 19, 2026), with a median of $70.0275 per EA.
Are there cheaper alternatives to DESCOVY 200-25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DESCOVY 200-25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DESCOVY 200-25 MG TABLET?
DESCOVY 200-25 MG TABLET (NDC 61958200202) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.